en

PRODUCT DETAIL

Amlessa Neo 5 mg/5 mg tablety

Code 9954D
MA number 58/0066/22-S
Product Form: tbl 120x5 mg/5 mg (blis.OPA/Al/PVC//Al)
MA Status: R - Valid Marketing Authorisation
Type of procedure: Decentralised
MAH, country: KRKA, d.d., Novo mesto, Slovenia
Therapeutic Class: 58 - HYPOTENSIVA
ATC:
C CARDIOVASCULAR SYSTEM
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM
C09B ACE INHIBITORS, COMBINATIONS
C09BB ACE inhibitors and calcium channel blockers
C09BB04 Perindopril and amlodipine
Shelf life: 24
Container: blister OPA/Al/PVC/Al
Route of admin.: Oral use
Prescription Status: Medicinal product subject to medical prescription.
Legal basis: Article 10(1) generic application
MA issued: 01.04.2022
Validity: 01.04.2027
SPC: SPC_Amlessa Neo_tbl_04_2024.pdf  
PIL: PIL_Amlessa Neo_tbl_04_2024.pdf  
Safety feature Yes
Data update: 07.04.2022
eu-flag.png sk-flag.png